Cited by 78Hormonal and reproductive studiesCardiovascular Health and Disease PreventionSexual function and dysfunction studies

Effect of testosterone replacement therapy on arterial stiffness in older hypogonadal men

Yaron, Marianna, Greenman, Yona, Rosenfeld, Joseph B, Izkhakov, Elena, Limor, Rona, Osher, Etty, Shenkerman, Galina, Tordjman, Karen +1 more·2009·European Journal of Endocrinology

Abstract

Objective: To assess arterial stiffness in a cohort of hypogonadal males and to investigate the effect of testosterone replacement therapy on arterial properties in this specific group. Design: Eighteen male patients with untreated acquired hypogonadism due to either adult-onset idiopathic hypogonadotropic hypogonadism ( n =9) or pituitary tumor ( n =9) and 12 age-, sex, and weight-matched eugonadal healthy controls were recruited for the study. Arterial properties, plasma glucose, lipid profile, total, and bioavailable testosterone (BT) levels were measured in fasting state. In the hypogonadal subjects, the effect of transdermal testosterone replacement therapy on arterial properties was studied by repeat noninvasive measurements at baseline, as well as 48 h and 90 days following the initiation of treatment. Methods: Arterial stiffness was evaluated using applanation tonometry and pulse wave analysis by three different standard devices that assess various measures of arterial stiffness: pulse wave velocity (PWV), augmentation index (AIx), and large/small artery compliance (C1 and C2). Results: Age- and blood pressure-adjusted PWV was significantly higher in hypogonadal men (8.90±2.29 vs 6.78±1.16 m/s in the control group; P =0.025). Testosterone therapy increased BT level from 2.01±1.04 to 4.68±2.43 and 7.83±6.2 nmol/l after 48 h and 3 months respectively ( P =0.001). PWV decreased from 8.9±2.29 to 8.24±1.39 and 8.25±1.82 m/s after 48 h and 3 months of treatment respectively ( P =0.03). Conclusions: Male hypogonadism is associated with increased PWV, which is rapidly but incompletely ameliorated by normalization of circulating testosterone levels.

Integrity signals

Registry

Crossref · 10.1530/eje-09-0052

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Yaron, M., Greenman, Y., Rosenfeld, J. B., Izkhakov, E., Limor, R., Osher, E., Shenkerman, G., Tordjman, K., & Stern, N.
Affiliations
Tel Aviv University (IL)
Corresponding author
Stern, Naftali
Venue
European Journal of Endocrinology
Published
2009-05
Volume
160
Issue
5
Pages
839-846
ISSN
  • 0804-4643 (ISSN-L)
  • 1479-683X
OpenAlex
W2133761842
Cited by
78
References
39
Citations by year
2026: 4 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 5 · 2021: 5 · 2020: 5 · 2019: 4 · 2018: 2 · 2017: 4 · 2016: 2 · 2015: 8 · 2014: 4 · 2013: 7 · 2012: 9
FWCI
5.81
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
  • Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
Keywords
testosterone replacement therapy, arterial stiffness, male hypogonadism, pulse wave velocity, idiopathic hypogonadotropic hypogonadism, pituitary tumors, transdermal testosterone, applanation tonometry, pulse wave analysis, arterial compliance, older men
MeSH terms
Age Factors, Aged, Arteries, Blood Flow Velocity, Blood Pressure, Follicle Stimulating Hormone, Humans, Hypogonadism, Luteinizing Hormone, Male, Middle Aged, Prolactin, Testosterone, Vascular Resistance, Age of Onset, Hormone Replacement Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review